These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 7643090)

  • 1. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
    Farrell CB; Lawlor M; Dunne A; O'Boyle KM
    J Neurochem; 1995 Sep; 65(3):1124-30. PubMed ID: 7643090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of [3H]SCH 23390 dissociation from rat striatal dopamine D1 receptors: effect of dopamine.
    Farrell CB; O'Boyle KM
    Eur J Pharmacol; 1994 Jun; 268(1):79-88. PubMed ID: 7925614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK; Ross GM; Bajwa SB; Mishra RK
    Neurochem Res; 1990 Jun; 15(6):647-57. PubMed ID: 1977093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
    O'Boyle KM; Waddington JL
    Neuropharmacology; 1992 Feb; 31(2):177-83. PubMed ID: 1532443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
    Niznik HB; Otsuka NY; Dumbrille-Ross A; Grigoriadis D; Tirpak A; Seeman P
    J Biol Chem; 1986 Jun; 261(18):8397-406. PubMed ID: 3522568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis.
    West AR; Grace AA
    J Neurosci; 2002 Jan; 22(1):294-304. PubMed ID: 11756513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptors in canine caudate nucleus.
    Maeno H
    Mol Cell Biochem; 1982 Mar; 43(2):65-80. PubMed ID: 6123940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH; Gnegy ME
    Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered dopamine receptor mediated signal transmission in the striatum of aged rats.
    May T; Sugawa M
    Brain Res; 1993 Feb; 604(1-2):106-11. PubMed ID: 8457839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
    Dong ZJ; Chen LJ; Jin GZ; Creese I
    Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-induced reduction in the density of guanine nucleotide-sensitive D1 receptors in human postmortem brain in the absence of apparent D1: D2 interactions.
    McCauley PG; O'Boyle KM; Waddington JL
    Neuropharmacology; 1995 Jul; 34(7):777-83. PubMed ID: 8532144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
    LaHoste GJ; Marshall JF
    Neuroscience; 1991; 41(2-3):473-81. PubMed ID: 1678501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.